Skip to content

Natural History of Melody Valve in the Mitral and Tricuspid Position

Natural History of Melody Valve in the Mitral and Tricuspid Position

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02505074
Enrollment
100
Registered
2015-07-22
Start date
2014-12-01
Completion date
2025-06-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of Mitral Valve, Tricuspid Valve Disorder

Keywords

mitral valve, tricuspid valve, Melody valve

Brief summary

The Melody valve has historically been used for pulmonary valve replacements; however it has been more recently used in the mitral and tricuspid positions. This multi-center, retrospective, observational study will review the durability of the Melody valve inserted into the mitral or tricuspid positions. Patients who have undergone Melody valve insertion into either the mitral or tricuspid positions prior to December, 2014 will be eligible for the study. Basic de-identified patient demographics will be collected as well as select clinical data. Ventricular function and valvar function of the affected valve will be retrospectively reviewed both prior to surgery and following, as well as review of operative data. The investigators will also review the most recent follow up data and any subsequent re-interventions on the Melody valve. Data from all sites will be entered into an external REDCap database, using only de-identified data.

Detailed description

Prior to recent advancement in using the Melody valve for atrioventricular valve replacement, there have only been fixed diameter valve options for severe valve disease requiring replacement. This presents numerous obstacles for those pediatric patients who require replacement early in life, as the fixed diameter does not offer options for expansion for somatic growth, and early reoperation will be required. The Melody valve has been approved for transcatheter implantation into the RVOT (right ventricular outflow tract), and has shown competence within a range of sizes. Recent studies conducted at Boston Children's Hospital of off-label use of the Melody valve into atrioventricular valve positions have shown acceptable short-term valve performance, and that subsequent catheter-based expansion is feasible.

Interventions

PROCEDUREValve replacement with the Melody valve

This study will only review patients who have had the Melody valve surgically inserted into the Mitral and/or Tricuspid positions. We will not be reviewing any other intervention type.

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
MOUNT SINAI HOSPITAL
CollaboratorOTHER
Children's Hospital and Medical Center
CollaboratorUNKNOWN
University of California, San Francisco
CollaboratorOTHER
NewYork Presbyterian Hospital
CollaboratorUNKNOWN
Monroe Carell Jr. Children's Hospital at Vanderbilt
CollaboratorOTHER
Northwell Health
CollaboratorOTHER
Primary Children's Hospital
CollaboratorOTHER
Seattle Children's Hospital
CollaboratorOTHER
Gruppo Ospedaliero San Donato
CollaboratorUNKNOWN
University Hospital Munich
CollaboratorOTHER
University Children's Hospital, Zurich
CollaboratorOTHER
Fondation IUCPQ
CollaboratorOTHER
Hospital for Sick Kids
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* All patients who have had a Melody valve inserted into either mitral or tricuspid positions via surgical intervention

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frame
Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by degree of stenosis in Melody valveup to 5 years
Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by grade of regurgitation in Melody valveup to 5 years
Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by number of necessary re-interventions of Melody valveup to 5 years

Contacts

PRINCIPAL_INVESTIGATORSitaram Emani, MD

Cardiovascular Surgeon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026